Table 1.
Sex difference interaction effect size (women vs. men [reference]) [risk ratio (95% CI)] | p | |
---|---|---|
Head-to-head comparisons | ||
Varenicline vs. TN | 1.19 (1.01, 1.40) | .04 |
Varenicline vs. bupropion SR | 1.22 (1.02, 1.47) | .03 |
Bupropion SR vs. TN | 0.97 (0.79, 1.19) | .77 |
Comparisons to placebo | ||
Varenicline vs. Placebo | 1.01 (0.86, 1.19) | .89 |
TN vs. Placebo | 0.85 (0.71, 1.02) | .08 |
Bupropion SR vs. Placebo | 0.83 (0.68, 1.01) | .06 |
CI = confidence interval; SR = sustained release; TN = Transdermal nicotine. p-values < .05 were considered statistically significant.